IDT Biologika   Report issue

For profit Phase 1
Founded: Dessau Germany (1921)

Organization Overview

First Clinical Trial
2020
NCT04119440
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

IDT Biologika | IDT Biologika Dessau.Rossau

Active Ingredients

Drugs in Phase 1 Trials (2)

mva-mers-s_df1 (1 trial)

mva-sars-2-s vaccinations (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Coronavirus Infections (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 3
  • # of Trial APIs: 2